Back
Lumos Pharma Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
44
LUMO
Lumos Pharma
Last Price:
4.35
Seasonality Move:
11.36%
Sell
16
NBY
NovaBay Pharmaceuticals
Last Price:
0.55
Seasonality Move:
-8.54%
Sell
44
Lumos Pharma (LUMO)
is a Sell
Is Lumos Pharma a Buy, Sell or Hold?
- The current Lumos Pharma [LUMO] share price is $4.34. The Score for LUMO is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- LUMO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
16
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.53. The Score for NBY is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
LUMO Stock Price Chart
What is Lumos Pharma's stock price today?
-
The Lumos Pharma share price today is $4.34
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LUMO is experiencing selling pressure, which indicates risk of future bearish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.53
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.
LUMO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 55.58 | Buy |
Chaikin Money Flow: | -321125 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.31 - 4.35) | Buy |
Bollinger Bands (100): | (2.72 - 4.5) | Buy |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 32.51 | Sell |
Chaikin Money Flow: | -111892 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.58 - 0.72) | Sell |
Bollinger Bands (100): | (0.35 - 0.97) | Sell |
LUMO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.34 | Sell |
20-day SMA: | 4.33 | Buy |
50-day SMA: | 4.18 | Buy |
200-day SMA: | 3.08 | Buy |
8-day EMA: | 4.33 | Buy |
20-day EMA: | 4.32 | Buy |
50-day EMA: | 4.14 | Buy |
200-day EMA: | 3.45 | Buy |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.58 | Sell |
20-day SMA: | 0.64 | Sell |
50-day SMA: | 0.65 | Sell |
200-day SMA: | 2.04 | Sell |
8-day EMA: | 0.58 | Sell |
20-day EMA: | 0.62 | Sell |
50-day EMA: | 0.68 | Sell |
200-day EMA: | 5 | Sell |
Lumos Pharma Earnings Growth & LUMO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.59 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $2.11 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.
Lumos Pharma Technical Analysis
Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |